1. Home
  2. DARE vs BNGO Comparison

DARE vs BNGO Comparison

Compare DARE & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DARE
  • BNGO
  • Stock Information
  • Founded
  • DARE 2015
  • BNGO 2003
  • Country
  • DARE United States
  • BNGO United States
  • Employees
  • DARE N/A
  • BNGO N/A
  • Industry
  • DARE Biotechnology: Pharmaceutical Preparations
  • BNGO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • DARE Health Care
  • BNGO Industrials
  • Exchange
  • DARE Nasdaq
  • BNGO Nasdaq
  • Market Cap
  • DARE 26.3M
  • BNGO 24.3M
  • IPO Year
  • DARE N/A
  • BNGO 2018
  • Fundamental
  • Price
  • DARE $2.20
  • BNGO $3.04
  • Analyst Decision
  • DARE Strong Buy
  • BNGO Buy
  • Analyst Count
  • DARE 1
  • BNGO 5
  • Target Price
  • DARE $12.00
  • BNGO $7.33
  • AVG Volume (30 Days)
  • DARE 340.6K
  • BNGO 110.7K
  • Earning Date
  • DARE 08-14-2025
  • BNGO 08-14-2025
  • Dividend Yield
  • DARE N/A
  • BNGO N/A
  • EPS Growth
  • DARE N/A
  • BNGO N/A
  • EPS
  • DARE N/A
  • BNGO N/A
  • Revenue
  • DARE N/A
  • BNGO $27,426,000.00
  • Revenue This Year
  • DARE $74,787.57
  • BNGO N/A
  • Revenue Next Year
  • DARE $141.76
  • BNGO $15.54
  • P/E Ratio
  • DARE N/A
  • BNGO N/A
  • Revenue Growth
  • DARE N/A
  • BNGO N/A
  • 52 Week Low
  • DARE $1.83
  • BNGO $2.68
  • 52 Week High
  • DARE $9.19
  • BNGO $37.09
  • Technical
  • Relative Strength Index (RSI)
  • DARE 43.48
  • BNGO 42.36
  • Support Level
  • DARE $1.83
  • BNGO $2.92
  • Resistance Level
  • DARE $2.50
  • BNGO $3.33
  • Average True Range (ATR)
  • DARE 0.15
  • BNGO 0.16
  • MACD
  • DARE -0.01
  • BNGO 0.02
  • Stochastic Oscillator
  • DARE 50.68
  • BNGO 33.33

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: